Infection Surveillance Solutions Market to Grow with CAGR of 11.16% through 2028

Increasing prevalence of hospital-acquired infections and growing investments to improve healthcare systems by AI integration is expected to drive the Global Infection Surveillance Solutions Market growth in the forecast period, 2024-2028.

 

According to TechSci Research report, “Infection Surveillance Solutions Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018–2028F”, the Global Infection Surveillance Solutions Market stood at USD 557.21 Million in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 11.16% through 2028. The global infection surveillance market is experiencing significant growth due to several key factors. These include the rising incidence of healthcare-associated infections (HAIs), an increase in the number of surgeries, the introduction of government protocols for HAI prevention, the growth of global healthcare expenditure, the convenience of software system handling, and improvements in healthcare insurance sectors. However, challenges such as the high cost of software, lack of proper knowledge, and medical professionals' hesitation towards advanced healthcare aids hinder market growth. Technological advancements in the IT sector have led to the development of fully automated diagnostic surveillance solutions that incorporate electronic medical records. This presents opportunities for market growth. The demand for infection surveillance is driven by the need to mitigate hospital-acquired infections and other epidemics. Infection surveillance solutions continuously monitor and interpret health data to ensure accurate implementation of preventive measures. Healthcare-associated infections encompass a range of infections that patients acquire during medical or surgical treatment, many of which are preventable. These include catheter-associated urinary tract infections, surgical site infections, pneumonia, and influenza. To address these challenges, hospitals and healthcare centers are turning to software analytical tools for infection surveillance. These analytics help organize and interpret health data, investigating various parameters to implement and assess public health practices in controlling the frequency of healthcare-associated infections. The usability and impact of these solutions on the healthcare ecosystem are significant, prompting governments to adopt them. Initiatives like the National Action Plan to Prevent Healthcare-Associated Infections in the United States, which includes increasing coverage of healthcare personnel for influenza and pneumonia, demonstrate the commitment to eliminating HAIs. Funding from organizations like the NIH further supports efforts to curb common HAIs. Infection surveillance solutions play a crucial role in supporting these initiatives.

Pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and infections associated with certain surgeries are among the significant Healthcare-Acquired Infections (HAIs). The high incidence of HAIs is a major concern for governments worldwide, leading them to establish policies aimed at effectively managing and reducing such occurrences. The market growth is expected to be driven by the increasing adoption of inorganic growth strategies, such as acquisitions, by key players in the industry to expand their product portfolios. For example, in May 2019, RLDatix, a software company, announced its acquisition of iContracts, a provider of cloud-based contract, compliance, and revenue management software across multiple industries. This acquisition combines RLDatix's patient safety platform with iContracts' leading policy management capabilities, enabling organizations to address the root causes of incidents through the implementation of dynamic policies and procedures.

In conclusion, the aforementioned factors drive vendors in the market to expand their presence in new markets, addressing the growing need for effective infection surveillance solutions.

On the contrary, the high cost associated with the software, hesitancy among medical professionals to adopt advanced healthcare tools, and shortage of skilled IT professionals to operate act as factors that are expected to impede the growth of the infection surveillance solutions systems market. The increasing demand for web-based solutions and mobile platforms, as well as the consumer preference for automation in healthcare facilities, are anticipated to pose challenges to the infection surveillance solutions systems market in the forecast period of 2023-2028.

 

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Infection Surveillance Solutions Market.”

 

The Global Infection Surveillance Solutions Market is segmented into offering, end user, regional distribution, and company.

Based on end user, the infection surveillance solutions market is segmented into hospitals, and long-term care facilities. Among these segments, hospitals accounted for the largest share and are expected to witness the highest growth during the forecast period. The high incidence of healthcare-associated infections (HAIs) and the resulting financial burden on stakeholders have led to increased adoption of infection control products and services in hospitals. Additionally, the market is driven by the large patient volume and the rising cases of surgical site infections (SSIs). Common HAIs reported in hospitals include central line-associated bloodstream infections, methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant enterococci bloodstream infections, Clostridium difficile infections, and SSIs.

Based on region, North America segment is expected to grow during the forecast period. North America stands as one of the largest global markets for medical technology research industries. The region's significant market presence can be attributed to the burgeoning R&D activities in the field of medical sciences. Notably, the United States of America's Health and Human Services (HHS), governed by the cabinet-level department of the US federal government, exhibits a liberal approach in funding and sustaining technological research in medical sciences. Studies have also indicated that in the United States, 1 out of every 25 hospitalized patients suffers from Healthcare-Associated Infections (HAIs). Given that a substantial portion of these infections occur in intensive care units (ICUs), hospitals face challenges in reducing the infection rate. To address these concerns, the US Department of Health and Human Services has prioritized and nationalized the reduction of HAIs, aiming to establish a safer and more cost-effective healthcare system for all Americans. Furthermore, the escalating healthcare costs in the United States are compelling individual hospitals to consider relocation or consolidation with independent healthcare groups, forming larger healthcare systems. These integrated systems aim to expand their service coverage, capitalize on economies of scale, and withstand mounting regulatory pressures imposed by the government. These dynamics significantly impact the growth of technological advancements within hospitals, consequently propelling the market for infection surveillance solutions.

 

Major companies operating in Global Infection Surveillance Solutions Market are:

• Cerner Corporation
• Epic Systems Corporation
• VigiLanz Corporation
• Becton, Dickinson and Company
• Premier Inc.
• DEB Group Ltd
• RL Solutions
• Baxter International Inc. (ICNet International)
• Gojo Industries Inc.
• IBM Corporation (Truven Health Analytics)

 

Download Free Sample Report

Customers can also request for 10% free customization on this report.

 

“The increasing prevalence of hospital-acquired infections (HAIs) due to poor hygienic conditions and negligence by medical staff is a significant driver of the market. Furthermore, governments of numerous countries are undertaking initiatives to improve the quality of care, patient safety, and HAI prevention. This, combined with the rising healthcare expenditure and high adoption rate of advanced IT systems for electronic healthcare records (EHR) in hospitals, is fueling market growth. Additionally, the growing geriatric population and the rising number of surgeries worldwide are positively impacting the market for infection surveillance solutions. Moreover, healthcare information and technology (IT) companies are introducing innovative solutions in data management, analytics, and infrastructure, facilitating convenient data collection of infections and epidemics. This, along with developments in surveillance solutions to aid medical staff in software understanding and usage, is bolstering market growth. Furthermore, key players operating in the market are expected to benefit from increasing adoption of cloud-based software and the growing demand for web-based solutions and mobile platforms, presenting lucrative growth opportunities.,” said Mr. Karan Chechi, Research Director with TechSci Research, a research-based management consulting firm.

“Infection Surveillance Solutions Market Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Offering (Software, Service), By End User (Hospitals, Long-term Care Facilities), By Region and Competition”, has evaluated the future growth potential of Global Infection Surveillance Solutions Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Infection Surveillance Solutions Market.

 

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: www.techsciresearch.com